Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
AVDL
#1626
Avadel Pharmaceuticals plc
21.640
0
+0.05%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+0.05%
Variazione Mensile
+0.70%
Variazione di 6 mesi
+16.66%
Variazione Annuale
+16.66%
Chiusura Precedente
21.630
0
Open
21.640
0
Bid
Ask
Low
21.640
0
High
21.640
0
Volume
1 054
Mercati
Mercato Azionario Statunitense
Salute
AVDL
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.47 M
59.03 M
64.48 M
90.58 M
96.63 M
—
Valuation ratios
Enterprise value
—
—
—
—
964.2 M
3.87 B
Price to earnings ratio
—
—
—
—
-20.61
1 033.78
Price to sales ratio
—
—
—
—
5.91
19.71
Price to cash flow ratio
—
—
—
—
21.32
380.06
Price to book ratio
—
—
—
—
13.54
23.3
Enterprise value to EBITDA ratio
—
—
—
—
-22.81
—
Profitability ratios
Return on assets %
0.02
-0.31
-1.04
-0.97
-0.3
-0.11
Return on equity %
0.04
-0.99
-6.5
-1.83
-0.66
-0.24
Return on invested capital %
-18.66
-138.33
-237.71
-1 055.02
-455.01
-52.75
Gross margin %
74.29
—
—
96.97
90.97
375.8
Operating margin %
26.04
—
—
-492.97
-25.07
-13.27
EBITDA margin %
275.6
—
—
-482.06
-24.99
—
Net margin %
31.47
—
—
-573.17
-28.87
-32.31
Liquidity ratios
Quick ratio
17.44
—
—
3.36
2.33
9.42
Current ratio
17.44
9.17
1.81
3.64
2.75
11.03
Inventory turnover
3.22
—
—
0.16
1
0.65
Asset turnover
0.1
0
0
0.19
1.03
1.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.41
0.58
0.69
0
—
—
Long term debt to total equity ratio
0.79
1.82
4.33
0
—
—
Per share metrics
Operating cash flow per share
-0.89
-1.32
-1.17
-1.6
-0.49
0.35
EBIT per share
0.99
-0.17
—
-1.72
-0.45
0.04
EBITDA per share
1.12
-0.14
—
-1.68
-0.44
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.33
0.87
1.61
1.31
0.78
3.21
Net current asset value per share
4.8
3.29
1.68
1.67
1.41
6.19
Tangible book value per share
2.65
1.05
0.07
0.88
0.6
2.75
Working capital per share
4.52
2.93
0.75
1.21
0.9
3.94
Book value per share
2.95
1.34
0.35
1.09
0.78
3.44
Notizie
I risultati di Alkermes in arrivo mentre prende forma la strategia sul sonno
Alkermes earnings up next as sleep strategy takes shape
Harmony Biosciences Makes The Grade (NASDAQ:HRMY)
Obiettivo di prezzo di Alkermes alzato a $47 da $46 da UBS dopo l’accordo con Avadel
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal
BlackRock rivela una partecipazione del 6,94% in Avadel Pharmaceuticals
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals
TIG Advisors rivela una partecipazione del 4,18% in Avadel Pharmaceuticals
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals
Goldman Sachs rivela posizione di trading in Avadel Pharmaceuticals
Goldman Sachs discloses trading position in Avadel Pharmaceuticals
Janus Henderson rivela una partecipazione dell’1,87% in Avadel Pharmaceuticals